{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:52:59Z","timestamp":1790639579739,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["Mobilnosc Plus"],"award-info":[{"award-number":["Mobilnosc Plus"]}]},{"name":"Eugene Devic European Network","award":["European research project on rare diseases ERA-Net E-RARE-2"],"award-info":[{"award-number":["European research project on rare diseases ERA-Net E-RARE-2"]}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["DFG Exc 257"],"award-info":[{"award-number":["DFG Exc 257"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Ministry for Education and Research","award":["DFG Exc 257"],"award-info":[{"award-number":["DFG Exc 257"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00415-015-7952-8","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T06:36:53Z","timestamp":1446532613000},"page":"140-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO\/MS overlap syndromes"],"prefix":"10.1007","volume":"263","author":[{"given":"Maciej","family":"Jury\u0144czyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsen","family":"Akman-Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Boggild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"D\u2019hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Evangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Geraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kleiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McGuigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekha","family":"Pandit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Selmaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"de S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksel","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Wingerchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Wren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"7952_CR1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon V, Lucchinetti CF et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805\u2013815. doi: 10.1016\/S1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"key":"7952_CR2","first-page":"2106","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: Lancet 364:2106\u20132112","journal-title":"A serum autoantibody marker of neuromyelitis optica: Lancet"},{"key":"7952_CR3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ et al (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477. doi: 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"7952_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/practneurol-2012-000237","volume":"12","author":"J Palace","year":"2012","unstructured":"Palace J, Leite MI, Leite I, Jacob A (2012) A practical guide to the treatment of neuromyelitis optica. Pract Neurol 12:209\u2013214. doi: 10.1136\/practneurol-2012-000237","journal-title":"Pract Neurol"},{"key":"7952_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","volume":"86","author":"M Jury\u0144czyk","year":"2015","unstructured":"Jury\u0144czyk M, Craner M, Palace J (2015) Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. J Neurol Neurosurg Psychiatry 86:20\u201325. doi: 10.1136\/jnnp-2014-308984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7952_CR6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","volume":"80","author":"L Matthews","year":"2013","unstructured":"Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80:1330\u20131337. doi: 10.1212\/01.wnl.0000436079.95856.1f","journal-title":"Neurology"},{"key":"7952_CR7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","volume":"67","author":"J Palace","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A (2010) Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol 67:1016\u20131017. doi: 10.1001\/archneurol.2010.188","journal-title":"Arch Neurol"},{"key":"7952_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archneurol.2011.216","volume":"69","author":"I Kleiter","year":"2012","unstructured":"Kleiter I, Hellwig K, Berthele A et al (2012) Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica. Arch Neurol 69:239\u2013245. doi: 10.1001\/archneurol.2011.216","journal-title":"Arch Neurol"},{"key":"7952_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1212\/WNL.0b013e31826845fe","volume":"79","author":"A Jacob","year":"2012","unstructured":"Jacob A, Kelly S, Ali R, Optica N (2012) Does Natalizumab Therapy Worsen Neuromyelitis Optica? Neurology 79:1065\u20131069","journal-title":"Neurology"},{"key":"7952_CR10","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00415-013-6965-4","volume":"260","author":"M Jury\u0144czyk","year":"2013","unstructured":"Jury\u0144czyk M, Zaleski K, Selmaj K (2013) Natalizumab and the development of extensive brain lesions in neuromyelitis optica. J Neurol 260:1919\u20131921. doi: 10.1007\/s00415-013-6965-4","journal-title":"J Neurol"},{"key":"7952_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1352458511431973","volume":"18","author":"J-H Min","year":"2012","unstructured":"Min J-H, Kim BJ, Lee KH (2012) Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder. Mult Scler J 18:113\u2013115. doi: 10.1177\/1352458511431973","journal-title":"Mult Scler J"},{"key":"7952_CR12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P et al (2012) Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273\u20131277. doi: 10.1212\/WNL.0b013e31826aac4e","journal-title":"Neurology"},{"key":"7952_CR13","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M et al (2014) Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. doi: 10.1001\/jamaneurol.2013.5857","journal-title":"JAMA Neurol"},{"key":"7952_CR14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","volume":"82","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA et al (2014) Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82:474\u2013481. doi: 10.1212\/WNL.0000000000000101","journal-title":"Neurology"},{"key":"7952_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1037\/h0031619","volume":"76","author":"JL Fleiss","year":"1971","unstructured":"Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76:378\u2013382","journal-title":"Psychol Bull"},{"key":"7952_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"7952_CR17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520\u2013532. doi: 10.1016\/S1474-4422(10)70064-8","journal-title":"Lancet Neurol"},{"key":"7952_CR18","author":"G Tackley","year":"2014","unstructured":"Tackley G, Kuker W, Palace J (2014) Magnetic resonance imaging in neuromyelitis optica. Mult Scler. doi: 10.1177\/1352458514531087","journal-title":"Mult Scler"},{"key":"7952_CR19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84:1165\u20131173. doi: 10.1212\/WNL.0000000000001367","journal-title":"Neurology"},{"key":"7952_CR20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489. doi: 10.1212\/01.wnl.0000216139.44259.74","journal-title":"Neurology"},{"key":"7952_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. doi: 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"7952_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458511406165","volume":"18","author":"JL Kitley","year":"2012","unstructured":"Kitley JL, Leite MI, George JS, Palace J (2012) The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler 18:271\u2013285. doi: 10.1177\/1352458511406165","journal-title":"Mult Scler"},{"key":"7952_CR23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2013.3890","volume":"70","author":"J Kitley","year":"2013","unstructured":"Kitley J, Leite MI, K\u00fcker W et al (2013) Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol 70:1375\u20131381. doi: 10.1001\/jamaneurol.2013.3890","journal-title":"JAMA Neurol"},{"key":"7952_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","volume":"72","author":"EP Flanagan","year":"2015","unstructured":"Flanagan EP, Weinshenker BG, Krecke KN et al (2015) Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders. JAMA Neurol 72:81\u201387. doi: 10.1001\/jamaneurol.2014.2137","journal-title":"JAMA Neurol"},{"key":"7952_CR25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","volume":"126","author":"D Kidd","year":"2003","unstructured":"Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276\u2013284","journal-title":"Brain"},{"key":"7952_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","volume":"261","author":"A Petzold","year":"2014","unstructured":"Petzold A, Plant GT (2014) Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 261:17\u201326. doi: 10.1007\/s00415-013-6957-4","journal-title":"J Neurol"},{"key":"7952_CR27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.38.2.180","volume":"38","author":"DW Paty","year":"1988","unstructured":"Paty DW, Oger JJ, Kastrukoff LF et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180\u2013185","journal-title":"Neurology"},{"key":"7952_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","volume":"13","author":"C Papeix","year":"2007","unstructured":"Papeix C, Vidal J-S, de Seze J et al (2007) Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13:256\u2013259. doi: 10.1177\/1352458506070732","journal-title":"Mult Scler"},{"key":"7952_CR29","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","volume":"130","author":"T Matsuoka","year":"2007","unstructured":"Matsuoka T, Matsushita T, Kawano Y et al (2007) Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130:1206\u20131223. doi: 10.1093\/brain\/awm027","journal-title":"Brain"},{"key":"7952_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-14-21","volume":"14","author":"J Kira","year":"2014","unstructured":"Kira J, Itoyama Y, Kikuchi S et al (2014) Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12\u00a0months: results of a phase 2 observational extension. BMC Neurol 14:21. doi: 10.1186\/1471-2377-14-21","journal-title":"BMC Neurol"},{"key":"7952_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(97)24030-4","volume":"350","author":"J Palace","year":"1997","unstructured":"Palace J, Rothwell P (1997) New treatments and azathioprine in multiple sclerosis. Lancet 350:261. doi: 10.1016\/S0140-6736(97)24030-4","journal-title":"Lancet"},{"key":"7952_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp-2013-305298","volume":"85","author":"L Michel","year":"2014","unstructured":"Michel L, Vukusic S, De Seze J et al (2014) Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients. J Neurol Neurosurg Psychiatry 85:279\u2013283. doi: 10.1136\/jnnp-2013-305298","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7952_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ana.410370108","volume":"37","author":"DE Goodkin","year":"1995","unstructured":"Goodkin DE, Rudick RA, VanderBrug Medendorp S et al (1995) Low-dose (7.5\u00a0mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 37:30\u201340. doi: 10.1002\/ana.410370108","journal-title":"Ann Neurol"},{"key":"7952_CR34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","volume":"358","author":"SL Hauser","year":"2008","unstructured":"Hauser SL, Waubant E, Arnold DL et al (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358:676\u2013688. doi: 10.1056\/NEJMoa0706383","journal-title":"N Engl J Med"},{"key":"7952_CR35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-141-10-200411160-00008","volume":"141","author":"JW Peabody","year":"2004","unstructured":"Peabody JW, Luck J, Glassman P et al (2004) Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 141:771\u2013780","journal-title":"Ann Intern Med"},{"key":"7952_CR36","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflam 2:e89","journal-title":"Neurol Neuroimmunol Neuroinflam"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7952-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7952-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7952-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:22:57Z","timestamp":1559056977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7952-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["7952"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7952-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}